Navigation Links
HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV
Date:9/23/2009

in the blood of those who became infected after they enrolled in the study.

More than 16,000 HIV-negative men and women between the ages of 18 to 30 participated in the study; half of these participants received the prime-boost vaccine regimen and half received placebo. Volunteers received vaccinations over the course of six-months and were followed for an additional three-years. Before agreeing to participate, all volunteers were informed of the potential risks associated with receiving the experimental vaccine regimen used in this study and consented to participate in the study. Volunteers continued to receive an HIV test every six-months for three-years following vaccination, in addition to counseling on how to prevent becoming infected with HIV.

For additional information, please visit www.hivresearch.org


'/>"/>
SOURCE U.S. Military HIV Research Program
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
6. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
7. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
8. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
9. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
10. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
11. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)...   VWR  (NASDAQ:  VWR), a leading, independent ... today the expansion of its distribution agreement with ... VWR increased access to NEB,s growing product portfolio ... Puerto Rico.  In addition, customers will now have ... sales organization, and VWRCATALYST, our onsite services organization. ...
(Date:3/3/2015)... March 3, 2015  RedHill Biopharma Ltd. ... Israeli biopharmaceutical company primarily focused on late ... gastrointestinal diseases, including gastrointestinal cancers, today announced ... Business Officer, will be presenting at VirtualInvestorConferences.com, ... Thursday, March 5, 2015, at 10:00 am ...
(Date:3/3/2015)... TUCSON, Ariz. , March 3, 2015  The ... where more than 450 of the world,s top research scientists, ... findings, discuss evolving theories and learn about new outcomes ... of medicine. Each year Ventana Medical ... Roche Group, sponsors the Tucson Symposium at the ...
Breaking Medicine Technology:VWR Announces Expansion of Distribution Agreement with New England Biolabs 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 4Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2
... Calif., Nov. 15, 2010 diaDexus, Inc. (OTC Bulletin Board: ... development and commercialization of patent-protected in vitro diagnostic ... results for the third quarter of 2010. Total revenues for ... growth over total revenues of $2.5 million for the third ...
... SPRING, Md., Nov. 15, 2010 The U.S. ... aimed at facilitating the development of safer, more ... rhythms through improved design and manufacturing practices. ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) External ...
Cached Medicine Technology:diaDexus, Inc. Reports 2010 Third Quarter Financial Results 2diaDexus, Inc. Reports 2010 Third Quarter Financial Results 3diaDexus, Inc. Reports 2010 Third Quarter Financial Results 4diaDexus, Inc. Reports 2010 Third Quarter Financial Results 5FDA Launches Initiative to Develop Innovative External Defibrillators 2FDA Launches Initiative to Develop Innovative External Defibrillators 3
(Date:3/3/2015)... Longtime parent visionary and inspiring new father, ... for a candid interview on the surrogacy process ... exhilarating revelation of his magical surrogacy journey — detailing ... to the birth of his precious twin girls. ... and Founder of CARE stated, “We are committed to ...
(Date:3/3/2015)... Man, Woman & Student of the ... cures and ensure access to treatments for blood cancer ... and their families. Through this annual national ten-week campaign, ... for a world without blood cancers. The national titles ... country, to be announced this summer. To date, these ...
(Date:3/3/2015)... 2015 The Rheumatology Nurses Society ... excellence in care and safe practice for patients with ... RNS that biologic infusions are administered in an infusion ... of a registered nurse (RN), as defined in their ... occur in patients receiving these medications during a first ...
(Date:3/3/2015)... 2015 The human augmentation market is ... market. The wearable augmentation sector is predicted to outpace ... the upcoming years. , The eye-wear sector dominates ... big number of new products launches in the region. ... technological advancements as well as the rising demand for ...
(Date:3/3/2015)... US Air Purifiers LLC , an Illinois ... pleased to announce that all Rabbit brand air purifiers are ... the west coast port strikes. This news comes just in ... , The port strikes, which have caused significant ... economic growth by as much as 1%, have hindered the ...
Breaking Medicine News(10 mins):Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3
... Jenifer Goodwin HealthDay Reporter , MONDAY, May 21 ... some artificial sweeteners, may worsen Crohn,s disease by encouraging the ... new study suggests. However, researchers stressed that the findings ... not in people, so it,s too soon to advise those ...
... fat removal procedures are beneficial for treating obesity and reducing ... can,t answer that question. They know that obesity increases the ... have not been clinical studies to determine if the surgical ... In animal studies, however, Rutgers scientists, who have published ...
... ATLANTA A team of researchers, including a scientist ... have found that a type of herpesvirus infection of ... (AMD), a disease that causes blindness in the elderly. ... of herpesvirus, causes the production of vascular endothelial growth ...
... Heart disease risk assessment tools commonly used by ... rheumatoid arthritis patients, a Mayo Clinic study ... in putting those with rheumatoid arthritis in greater jeopardy ... methods do not factor it in, the researchers note. ...
... Cincinnati design students Alex Broerman and Ashley Ma are on ... prescription-medicine pill bottle that better serves the needs of the ... inexpensive innovation. In fact, the two students have filed ... intended to have universal appeal but to fill the special ...
... distinction went to John Edward Solder, a senior at ... Optogenetic Interrogation of Prefrontal Cortex Dopamine D1 Receptor-Containing Neurons ... to Treat Prefrontal Disorders. The 18-year-old was able to ... modified to activate dopamine neurons in the prefrontal cortex, ...
Cached Medicine News:Health News:Could Compound in Artificial Sweeteners Worsen Crohn's Disease? 2Health News:Could Compound in Artificial Sweeteners Worsen Crohn's Disease? 3Health News:Surgical removal of abdominal fat reduces skin cancer in mice 2Health News:Type of viral infection of eye associated with disease causing blindness in the elderly 2Health News:Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis 2Health News:Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis 3Health News:UC students design a better pill bottle for the blind and visually impaired 2Health News:UC students design a better pill bottle for the blind and visually impaired 3Health News:Optogenetics project takes top NIDA Addiction Science Award 2Health News:Optogenetics project takes top NIDA Addiction Science Award 3Health News:Optogenetics project takes top NIDA Addiction Science Award 4
... a very versatile light source that ... of applications anytime a Zeiss stereomicroscope ... with optimum protection without heating the ... economical cold-light source that completes a ...
... from a complete line ... AC halogen light sources ... illumination. A solid-state dimmer ... and our exclusive Modulamp ...
Standard 20x long working distance objectives for greater magnifications of your microtools....
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark...
Medicine Products: